Literature DB >> 8488612

Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis: forme fruste of tuberous sclerosis?

L A Kerr1, M L Blute, J H Ryu, S J Swensen, R S Malek.   

Abstract

From 1976 to 1989, 27 patients with pulmonary lymphangioleiomyomatosis were seen at our institution. Twenty-five had no signs or symptoms of tuberous sclerosis; 21 of these had abdominal imaging or surgical exploration to make the diagnosis of renal angiomyolipoma in seven patients, all female. Three presented with symptoms secondary to renal disease, three with pulmonary manifestations, and one with both. Renal disease was bilateral in four patients; four patients underwent nephrectomy and two tumors were embolized. All patients experienced spontaneous pneumothoraces during the course of their disease. There was one respiratory death. It is our belief that any patient presenting with angiomyolipoma and a history of pulmonary problems should be evaluated for pulmonary lymphangioleiomyomatosis with a limited computed tomography scan of the chest at the time of abdominal imaging. The surgical treatment of angiomyolipoma when associated with lymphangioleiomyomatosis is predicated on the ability to adequately manage the complicating lung disease perioperatively.

Entities:  

Mesh:

Year:  1993        PMID: 8488612     DOI: 10.1016/0090-4295(93)90504-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

1.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas.

Authors:  Jay H Ryu; Thomas E Hartman; Vicente E Torres; Paul A Decker
Journal:  Chest       Date:  2011-07-07       Impact factor: 9.410

Review 3.  Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.

Authors:  Hen Prizant; Stephen R Hammes
Journal:  Endocrinology       Date:  2016-07-13       Impact factor: 4.736

4.  Giant angiomyolipoma associated with marked pulmonary lesions suggesting lymphangioleiomyomatosis in a patient with tuberous sclerosis.

Authors:  E Tüzel; Z Kirkali; U Mungan; C Cüler; M Sade
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

5.  Recognition of tuberous sclerosis in adult women: delayed presentation with life-threatening consequences.

Authors:  Diane Seibert; Chien-Hui Hong; Fumiko Takeuchi; Cara Olsen; Olonda Hathaway; Joel Moss; Thomas N Darling
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

6.  Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.

Authors:  T A Smolarek; L L Wessner; F X McCormack; J C Mylet; A G Menon; E P Henske
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

7.  Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.

Authors:  Rachel B Issaka; Saji Oommen; Shiv K Gupta; Gang Liu; Jeffrey L Myers; Jay H Ryu; Nicholas E Vlahakis
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

Review 8.  Lymphatic involvement in lymphangioleiomyomatosis.

Authors:  Connie G Glasgow; Angelo M Taveira-Dasilva; Thomas N Darling; Joel Moss
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

9.  Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex.

Authors:  Yanan Guo; John R Dreier; Juxiang Cao; Heng Du; Scott R Granter; David J Kwiatkowski
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

10.  Individual Copy Number of Ribosomal Genes as a Factor of Mental Retardation and Autism Risk and Severity.

Authors:  Lev Porokhovnik
Journal:  Cells       Date:  2019-09-26       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.